New York State Common Retirement Fund
AVDL

New York State Common Retirement Fund’s Avadel Pharmaceuticals AVDL Stock Holding History

New York State Common Retirement Fund’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,600
Closed -$573K – 3137
2025
Q4 		$573K Hold
26,600
– – ﹤0.01% 1921
2025
Q3 		$406K Hold
26,600
– – ﹤0.01% 2016
2025
Q2 		$235K Hold
26,600
– – ﹤0.01% 2190
2025
Q1 		$208K Sell
26,600
-4,600
-15% -$38.5K ﹤0.01% 2215
2024
Q4 		$328K Sell
31,200
-389,555
-93% -$4.73M ﹤0.01% 2102
2024
Q3 		$5.52M Buy
420,755
+383,355
+1,025% +$5.84M 0.01% 1054
2024
Q2 		$526K Sell
37,400
-362,151
-91% -$5.9M ﹤0.01% 2031
2024
Q1 		$6.75M Buy
+399,551
New +$5.95M 0.01% 990
2019
Q2 		– Sell
-6,217
Closed -$9K – 3244
2019
Q1 		$9K Sell
6,217
-9,338
-60% -$21.1K ﹤0.01% 3153
2018
Q4 		$40K Hold
15,555
– – ﹤0.01% 3108
2018
Q3 		$68K Hold
15,555
– – ﹤0.01% 3091
2018
Q2 		$95K Buy
+15,555
New +$109K ﹤0.01% 3094

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

New York State Common Retirement Fund's AVDL Position: Q1 2026 in Review

New York State Common Retirement Fund sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 26,600 shares — an estimated $573K sold.

New York State Common Retirement Fund first reported a position in AVDL in Q2 2018 and held it in 12 quarters. The position peaked at $6.75M in Q1 2024. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • New York State Common Retirement Fund reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 26,600 Avadel Pharmaceuticals shares in Q1 2026, an estimated $573K.
  • New York State Common Retirement Fund first reported a position in Avadel Pharmaceuticals in Q2 2018 and held it in 12 quarters.
  • New York State Common Retirement Fund's Avadel Pharmaceuticals position peaked at $6.75M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.